CAMPBELL, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the company’s board of directors has granted equity awards to Saurabh Sinha, the company’s Chief Financial Officer, as inducement awards material to Mr. Sinha’s acceptance of employment with the company under the company’s 2022 Employment Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).
The awards consist of (i) restricted stock units (RSUs) with a target grant value of $3,700,000, covering 142,835 shares of the company’s common stock, and (ii) performance stock units (PSUs) with a target grant value of $1,000,000, covering a target of 38,604 shares of the company’s common stock. In each case, the number of shares subject to the award was determined by dividing the target grant value by the 30-day trailing average price of the company’s common stock immediately prior to the effective date of the grant.
The RSUs vest as to 25% of the underlying shares on the first anniversary of the grant date, with the remainder vesting pro rata by day on the first day of each of the 12 consecutive fiscal quarters thereafter, aligned with fiscal quarterly vesting commencing January 1, 2028, in each case subject to Mr. Sinha’s continued service with the company through the applicable vesting date.
The PSUs vest upon satisfaction of two performance conditions: (i) the company achieving annual trailing four quarters’ publicly reported revenue of $200,000,000 or greater at any time on or before December 31, 2030; and subsequently (ii) the company’s common stock achieving a closing share price of $65 or greater, calculated as an average over a trading period of 15 trading days, at any time on or before December 31, 2031, in each case subject to Mr. Sinha’s continued service with the company through the applicable vesting date. In the event a change in control of the company occurs prior to the date the performance goals have been achieved, the PSUs shall not vest, and shall be forfeited for no consideration, effective upon the consummation of the change in control.
Mr. Sinha has entered into the company’s Form of Executive Change in Control Severance Agreement, which provides for full accelerated vesting of any unvested equity awards (except for any performance awards, including the PSUs, which are governed by the terms of the applicable award agreement) in the event of Mr. Sinha’s termination without cause or resignation for good reason during the period commencing three months prior to a change in control of the company and ending on the 12-month anniversary following such change in control.
The effective grant date of the awards was September 8, 2026, Mr. Sinha’s start date with the company, and the awards were approved by the company’s board of directors.
About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world's top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.
© 2004–2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.
Investor Contacts:
Arteris
Saurabh Sinha
Saurabh.Sinha@arteris.com
Sapphire Investor Relations, LLC
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com
Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
newsroom@arteris.com
This press release was published by a CLEAR® Verified individual.
